Nexus Pharmaceuticals, LLC announces the U.S. Food and Drug Administration (FDA) approval of Methylene Blue Injection, USP. Methylene Blue is an oxidation-reduction agent that offers treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback